entertainment -WSS

entertainment

author：comprehensive 2025-09-28 02:32:21 - browse：84627

gantenerumab Alzheimer's disease Roche — Sebastien Bozon/AFP via Getty Images

Roche said Monday it was buying Telavant Holdings for $7.1 billion upfront, picking up a promising experimental therapy for inflammatory bowel diseases.

Telavant is owned by Roivant Sciences, with Pfizer holding a minority stake. The deal will allow Roche to develop the therapy, called RVT-3101, and, pending approval, sell it in the United States and Japan. Pfizer holds the commercial rights in other parts of the world.

The “Roi” in Roivant stands for “return on investment” and with this deal, the biotech, founded by Republican presidential candidate Vivek Ramaswamy but now run by CEO Matt Gline, certainly delivered. Last December, it essentially acquired RVT-3101 from Pfizer for $45 million and a commitment to invest in the drug’s development. Less than a year later, Roivant flipped the drug to Roche for at least $7.1 billion.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Activists slam private health insurers over coverage restrictions
Next article： Biotech incubator Curie.Bio graduates its first startup

WSS

Medicare solvency divides Republicans at the presidential debate

Study: New antibiotic targets gonorrhea as well as last existing drug

Study: New antibiotic targets gonorrhea as well as last existing drug

Ambulance rides for just $100? Advisers want major billing fixes

Diversify hospital leadership teams to protect BIPOC patient health

Removing probiotics from the NICU could threaten preemies' health

hotspot

entertainment

leisure time

FDA approval of Sarepta Duchenne genetic therapy gives me hope

CRISPR technology availability, affordability needs to be expanded

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Don't let 'shelved assets' gather dust. Make them into new lifesaving drugs

Peter Hotez and the public health issue of online harassment

6 surprising facts about sugar

How one medical school became remarkably diverse

Abortion clinic in Cancun will cater to Americans

Activists slam private health insurers over coverage restrictions

FDA approves Recor Medical high blood pressure device

knowledge

Asbestos ban is immediate, but health effects will linger for decades

Feng Zhang suggests Editas didn’t move quickly enough to find product targets

Sanofi CEO defends move to abandon profit guidance, boost research

Ibogaine psychedelic therapy for opioid addiction unlikely, official says

Extreme heat events are a public health emergency

Diabetes management: Digital health tools fall short, study says

Wikipedia

knowledge

explore

explore